Enzo Biochem, Inc.
IMMUNE MODULATION FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION
Last updated:
Abstract:
The invention provides methods for treating age-related macular degeneration by administering (i) peptide compositions, (ii) regulatory T-cells from the patient or a compatible donor, or (iii) a combination of regulatory T-cells and said peptide compositions. Also provided are methods for diagnosing age-related macular degeneration and monitoring its progression.
Status:
Application
Type:
Utility
Filling date:
13 Jun 2019
Issue date:
17 Oct 2019